Not to rain on an otherwise positive 3X position on the call...BUT, In typical NP speak the issue of EUA should be considered muddled. NP said something to the effect that he believes “every international FDA needs P value endpoints study”. The he added something like “ in pandemic anything can happen so hopefully we are pursuing that ...blah blah blah.”
The P value comment is the one to bank on NOT the hopefully comment.